Original paper
Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis
Abstract
Background:
Non-alcoholic-steatohepatitis (NASH) leading to fibrosis, end-stage cirrhosis and hepatocellular carcinoma is an increasing health problem in the Western world. Thus, the need for new therapeutic approaches is increasing. IKK2 plays a key role in the development of NASH by mediating inflammation and insulin resistance.Aim:
Here the beneficial effects of a pharmacological IKK2 inhibitor (AS602868) on initial stages...Paper Details
Title
Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis
Published Date
Apr 11, 2008
Journal
Volume
57
Issue
5
Pages
655 - 663
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History